Literature DB >> 19379763

FANCM-FAAP24 and FANCJ: FA proteins that metabolize DNA.

Abdullah Mahmood Ali1, Thiyam Ramsing Singh, Amom Ruhikanta Meetei.   

Abstract

Fanconi anemia (FA) is a rare autosomal recessive or X-linked disorder characterized by aplastic anemia, cancer susceptibility and cellular sensitivity to DNA-crosslinking agents. Eight FA proteins (FANCA, -B, -C, -E, -F, -G, -L and -M) and three non-FA proteins (FAAP100, FAAP24 and HES1) form the FA nuclear core complex that is required for monoubiquitination of the FANCD2-FANCI dimer upon DNA damage. The other three FA proteins, FANCD1/BRCA2, FANCJ/BACH1/BRIP1 and FANCN/PALB2, act in parallel or downstream of the FANCD2-FANCI dimer. Despite the isolation and characterization of several FA proteins, the mechanism by which these proteins protect cells from DNA interstrand crosslinking agents has been unclear. This is because a majority of the FA proteins lack any recognizable functional domains that can provide insight into their function. The recently discovered FANCM (Hef) and FANCJ (BRIP1/BACH1) proteins contain helicase domains, providing potential insight into the role of FA proteins in DNA repair. FANCM with its partner, FAAP24, and FANCJ bind and metabolize a variety of DNA substrates. In this review, we focus on the discovery, structure, and function of the FANCM-FAAP24 and FANCJ proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19379763      PMCID: PMC2714411          DOI: 10.1016/j.mrfmmm.2009.04.002

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  44 in total

1.  The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway.

Authors:  Georgina Mosedale; Wojciech Niedzwiedz; Arno Alpi; Franco Perrina; Jose B Pereira-Leal; Mark Johnson; Frederic Langevin; Paul Pace; Ketan J Patel
Journal:  Nat Struct Mol Biol       Date:  2005-08-21       Impact factor: 15.369

2.  Activation of BRCA1/BRCA2-associated helicase BACH1 is required for timely progression through S phase.

Authors:  Easwari Kumaraswamy; Ramin Shiekhattar
Journal:  Mol Cell Biol       Date:  2007-07-30       Impact factor: 4.272

3.  Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM.

Authors:  Alberto Ciccia; Chen Ling; Rachel Coulthard; Zhijiang Yan; Yutong Xue; Amom Ruhikanta Meetei; El Houari Laghmani; Hans Joenje; Neil McDonald; Johan P de Winter; Weidong Wang; Stephen C West
Journal:  Mol Cell       Date:  2007-02-09       Impact factor: 17.970

4.  The Fanconi anemia protein FANCM can promote branch migration of Holliday junctions and replication forks.

Authors:  Kerstin Gari; Chantal Décaillet; Alicja Z Stasiak; Andrzej Stasiak; Angelos Constantinou
Journal:  Mol Cell       Date:  2008-01-18       Impact factor: 17.970

5.  Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24.

Authors:  Jung Min Kim; Younghoon Kee; Allan Gurtan; Alan D D'Andrea
Journal:  Blood       Date:  2008-01-03       Impact factor: 22.113

Review 6.  Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.

Authors:  Weidong Wang
Journal:  Nat Rev Genet       Date:  2007-09-04       Impact factor: 53.242

7.  FANCJ (BACH1) helicase forms DNA damage inducible foci with replication protein A and interacts physically and functionally with the single-stranded DNA-binding protein.

Authors:  Rigu Gupta; Sudha Sharma; Joshua A Sommers; Mark K Kenny; Sharon B Cantor; Robert M Brosh
Journal:  Blood       Date:  2007-06-27       Impact factor: 22.113

8.  The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells.

Authors:  Min Peng; Rachel Litman; Jenny Xie; Sudha Sharma; Robert M Brosh; Sharon B Cantor
Journal:  EMBO J       Date:  2007-06-21       Impact factor: 11.598

9.  DOG-1 is the Caenorhabditis elegans BRIP1/FANCJ homologue and functions in interstrand cross-link repair.

Authors:  Jillian L Youds; Louise J Barber; Jordan D Ward; Spencer J Collis; Nigel J O'Neil; Simon J Boulton; Ann M Rose
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

10.  HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability.

Authors:  Spencer J Collis; Louise J Barber; Allison J Clark; Julie S Martin; Jordan D Ward; Simon J Boulton
Journal:  Nat Cell Biol       Date:  2007-03-25       Impact factor: 28.824

View more
  16 in total

1.  Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance.

Authors:  James B Wilson; Eric Blom; Ryan Cunningham; Yuxuan Xiao; Gary M Kupfer; Nigel J Jones
Journal:  Mutat Res       Date:  2010-05-05       Impact factor: 2.433

2.  Purification of FANCD2 sub-complexes.

Authors:  Gang Zhi; Xiaoyong Chen; William Newcomb; Jay Brown; Oliver J Semmes; Gary M Kupfer
Journal:  Br J Haematol       Date:  2010-04-29       Impact factor: 6.998

3.  Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.

Authors:  Kumar Somyajit; Shreelakshmi Subramanya; Ganesh Nagaraju
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

Review 4.  Fanconi anaemia: from a monogenic disease to sporadic cancer.

Authors:  Antonio Valeri; Sandra Martínez; José A Casado; Juan A Bueren
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

5.  MHF1-MHF2, a histone-fold-containing protein complex, participates in the Fanconi anemia pathway via FANCM.

Authors:  Thiyam Ramsing Singh; Dorina Saro; Abdullah Mahmood Ali; Xiao-Feng Zheng; Chang-hu Du; Michael W Killen; Aristidis Sachpatzidis; Kebola Wahengbam; Andrew J Pierce; Yong Xiong; Patrick Sung; Amom Ruhikanta Meetei
Journal:  Mol Cell       Date:  2010-03-26       Impact factor: 17.970

6.  Fanconi anemia group J helicase and MRE11 nuclease interact to facilitate the DNA damage response.

Authors:  Avvaru N Suhasini; Joshua A Sommers; Parameswary A Muniandy; Yan Coulombe; Sharon B Cantor; Jean-Yves Masson; Michael M Seidman; Robert M Brosh
Journal:  Mol Cell Biol       Date:  2013-03-25       Impact factor: 4.272

Review 7.  The Fanconi anemia pathway and ICL repair: implications for cancer therapy.

Authors:  Lily C Wang; Jean Gautier
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10       Impact factor: 8.250

Review 8.  Expanded roles of the Fanconi anemia pathway in preserving genomic stability.

Authors:  Younghoon Kee; Alan D D'Andrea
Journal:  Genes Dev       Date:  2010-08-15       Impact factor: 11.361

9.  Fanconi anemia group J mutation abolishes its DNA repair function by uncoupling DNA translocation from helicase activity or disruption of protein-DNA complexes.

Authors:  Yuliang Wu; Joshua A Sommers; Avvaru N Suhasini; Thomas Leonard; Julianna S Deakyne; Alexander V Mazin; Kazuo Shin-Ya; Hiroyuki Kitao; Robert M Brosh
Journal:  Blood       Date:  2010-07-16       Impact factor: 22.113

Review 10.  RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.

Authors:  Kumar Somyajit; Shreelakshmi Subramanya; Ganesh Nagaraju
Journal:  Carcinogenesis       Date:  2010-10-15       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.